Skip to main content
An official website of the United States government

Aging Mammary Stem Cells and Breast Cancer Prevention

Research Group
Community Oncology and Prevention Trials
Sponsor
LuZhe Sun
Status
Terminated
NCT ID
NCT02642094
To examine whether rapamycin can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens
Intervention
Rapamycin
Condition
Cancer of Breast
Investigators
LuZhe Sun, PhD, Ismail Jatoi, MD

See list of participating sites